Eur Rev Med Pharmacol Sci 2021; 25 (20): 6158-6158
DOI: 10.26355/eurrev_202110_26971

Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate

J. Situ, H. Zhang, L. Lu, K. Li, C. Hu, D.-J. Wang

Department of Urology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou City, Guangdong Province, China.


The article “Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate, by J. Situ, H. Zhang, L. Lu, K. Li, C. Hu, D.-J. Wang, published in Eur Rev Med Pharmacol Sci 2017; 21 (15): 3347-3352–PMID: 28829509” has been withdrawn from the authors due to inaccuracies in the research design.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/13198

Free PDF Download

To cite this article

J. Situ, H. Zhang, L. Lu, K. Li, C. Hu, D.-J. Wang
Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 20
Pages: 6158-6158
DOI: 10.26355/eurrev_202110_26971